These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 4030111)

  • 21. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitive assays enable detection of serum IgG antibodies against Clostridium difficile toxin A and toxin B in healthy subjects and patients with Clostridium difficile infection.
    Zhao X; Bender F; Shukla R; Kang JJ; Caro-Aguilar I; Laterza OF
    Bioanalysis; 2016 Apr; 8(7):611-23. PubMed ID: 26964649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model.
    Qiu H; Cassan R; Johnstone D; Han X; Joyee AG; McQuoid M; Masi A; Merluza J; Hrehorak B; Reid R; Kennedy K; Tighe B; Rak C; Leonhardt M; Dupas B; Saward L; Berry JD; Nykiforuk CL
    PLoS One; 2016; 11(6):e0157970. PubMed ID: 27336843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical correlation of toxin and common antigen enzyme immunoassay testing in patients with Clostridium difficile disease.
    Lee SD; Turgeon DK; Ko CW; Fritsche TR; Surawicz CM
    Am J Gastroenterol; 2003 Jul; 98(7):1569-72. PubMed ID: 12873579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant single-chain variable fragment antibodies directed against Clostridium difficile toxin B produced by use of an optimized phage display system.
    Deng XK; Nesbit LA; Morrow KJ
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):587-95. PubMed ID: 12853390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease.
    Hourigan SK; Chirumamilla SR; Ross T; Golub JE; Rabizadeh S; Saeed SA; Elson CO; Kelly CP; Carroll KC; Oliva-Hemker M; Sears C
    Inflamm Bowel Dis; 2013 Dec; 19(13):2744-52. PubMed ID: 24145927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clostridium difficile toxin A and other enteropathogens in stool specimens of children hospitalized due to acute diarrhoea].
    Rozkiewicz D; Zaremba ML; Fiedoruk K; Daniluk T; Sciepuk M; Kurzatkowska B; Sulik A; Ołdak E
    Przegl Epidemiol; 2005; 59(3):711-21. PubMed ID: 16433313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated serum antibody response to toxin A following splenic abscess due to Clostridium difficile.
    Stieglbauer KT; Gruber SA; Johnson S
    Clin Infect Dis; 1995 Jan; 20(1):160-2. PubMed ID: 7727643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of Clostridium difficile toxins by enzyme immunoassay.
    Krishnan C
    J Hyg (Lond); 1986 Feb; 96(1):5-12. PubMed ID: 3950397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium difficile Infections in Children: Impact of the Diagnostic Method on Infection Rates.
    AlGhounaim M; Longtin Y; Gonzales M; Merckx J; Winters N; Quach C
    Infect Control Hosp Epidemiol; 2016 Sep; 37(9):1087-93. PubMed ID: 27263967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the diagnostic algorithm consisting of enzyme immunoassay for toxins and polymerase chain reaction, for the diagnosis of Clostridium difficile-associated diarrhoea.
    Lee JH; Park SJ; Lee YM; Lee CH; Cho JH
    Scand J Infect Dis; 2012 Dec; 44(12):969-72. PubMed ID: 22813084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
    Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
    Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A.
    Lyerly DM; Phelps CJ; Wilkins TD
    J Clin Microbiol; 1985 Jan; 21(1):12-4. PubMed ID: 3968199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenicity of amino-acid sequences from Clostridium difficile toxin B.
    Torres JF; Monath TP
    J Med Microbiol; 1996 Jun; 44(6):464-74. PubMed ID: 8636964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human antibody response to surface layer proteins in Clostridium difficile infection.
    Drudy D; Calabi E; Kyne L; Sougioultzis S; Kelly E; Fairweather N; Kelly CP
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):237-42. PubMed ID: 15196573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme immunoassay (ELISA) for detection of Clostridium difficile toxin B in specimens of faeces.
    Nguyen VK; Rihn B; Heckel C; Bisseret F; Girardot R; Monteil H
    J Med Microbiol; 1990 Apr; 31(4):251-7. PubMed ID: 2325114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of Clostridium difficile toxins in stools. Comparison between a new enzyme immunoassay for toxin A and other routine tests.
    Depitre C; Avesani V; Delmée M; Corthier G
    Gastroenterol Clin Biol; 1993; 17(4):283-6. PubMed ID: 8339887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters.
    Kim PH; Iaconis JP; Rolfe RD
    Infect Immun; 1987 Dec; 55(12):2984-92. PubMed ID: 3679541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of different methods for detection of Clostridium difficile toxins in Poland.
    Martirosian G; Pituch H; Obuch-Woszczatyński P; Rouyan G; Meisel-Mikołajczyk F
    Acta Microbiol Pol; 1999; 48(4):349-53. PubMed ID: 10756719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis.
    Salcedo J; Keates S; Pothoulakis C; Warny M; Castagliuolo I; LaMont JT; Kelly CP
    Gut; 1997 Sep; 41(3):366-70. PubMed ID: 9378393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.